ACM
HURA

Accent Capital Management’s TuHURA Biosciences HURA Stock Holding History

Accent Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.58K Sell
2,000
-1,500
-43% -$1.84K ﹤0.01% 303
2025
Q4 		$2.65K Sell
3,500
-3,500
-50% -$6.7K ﹤0.01% 335
2025
Q3 		$17.4K Hold
7,000
– – 0.01% 160
2025
Q2 		$15.6K Hold
7,000
– – 0.01% 181
2025
Q1 		$22.6K Hold
7,000
– – 0.01% 153
2024
Q4 		$28.6K Buy
+7,000
New +$37.2K 0.02% 98

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Accent Capital Management's HURA Position: Q1 2026 in Review

Accent Capital Management reduced its TuHURA Biosciences (HURA) stake by 43% in Q1 2026, selling an estimated $1.84K and leaving 2,000 shares worth $3.58K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

Accent Capital Management first reported a position in HURA in Q4 2024 and has held it in 6 quarters since. The position peaked at $28.6K in Q4 2024. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Accent Capital Management held 2,000 shares of TuHURA Biosciences worth $3.58K as of Q1 2026.
  • Accent Capital Management sold 1,500 TuHURA Biosciences shares in Q1 2026, an estimated $1.84K.
  • TuHURA Biosciences made up ﹤0.01% of Accent Capital Management's portfolio in Q1 2026, its #303 holding.
  • Accent Capital Management first reported a position in TuHURA Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Accent Capital Management's TuHURA Biosciences position peaked at $28.6K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.